Continuous Renal Replacement Therapy for Patients With Sepsis in a Low-Resource Medical Intensive Care Unit (MICU): Incidence, Risk Factors, and Outcomes

Le résumé fourni par la source

Introduction Sepsis is one of the leading causes of ICU admissions, with a substantial proportion of patients developing sepsis-associated acute kidney injury (S-AKI). In such cases, continuous renal replacement therapy (CRRT) is a cornerstone of renal supportive care; however, evidence from low-resource settings (LRS) remains limited. This study aimed to describe the demographic and clinical characteristics of patients with S-AKI treated with CRRT in an LRS medical ICU (MICU), as well as to identify predictors of mortality. Subjects and methods This retrospective, observational, consecutive, single-center study included adult patients admitted to the MICU between June 1, 2023, and June 1, 2024, with a diagnosis of sepsis complicated by S-AKI, and managed with CRRT. Statistical analyses were conducted using the Mann-Whitney U and Pearson χ² tests, and multinomial logistic regression was used to identify independent predictors of mortality. ORs were reported for key predictors, and Kaplan-Meier survival analysis was performed to assess time to event. Results A total of 96 patients with S-AKI were treated with CRRT (65 male patients, median age 64.5 years). The 28-day all-cause mortality rate was 69.8%, with a high rate of septic shock at admission among nonsurvivors (n=49, p= 0.019). Kaplan-Meier analysis demonstrated a median survival of 12 days (95%CI: 8.95-15.05). The majority of patients were admitted from hospital wards (n=59), and the most common comorbidities were hypertension (n=63), diabetes (n=38), and cardiomyopathy (n=27). Survivors had a longer MICU length of stay (p= 0.003). Nonsurvivors had a higher initial Sequential Organ Failure Assessment and Simplified Acute Physiology Score II (SAPS II) scores at MICU admission (p< 0.000), and prominent abnormalities at CRRT initiation for albumin (p= 0.004), troponine I (p= 0.032), and lactate (p= 0.004). Invasive mechanical ventilation and vasopressor therapy were predominantly used among nonsurvivors (p< 0.001). Continuous Venovenous Hemodiafiltration (CVVHDF) was the CRRT modality used for all patients (three patients used a combination of continuous and intermittent techniques), and hemoadsorption filters were used in 38 patients. The preferential indications for CVVHDF included anuria and profound metabolic acidosis, either in combination (n=51) or alone (n=17 and n=22). The most common sources of sepsis were pneumonia (n=42), urinary tract infection (n=13), multiple site infection (n=11), and abdomen (n=11). At MICU admission, blood cultures were positive in 34 patients (21 with gram-positive bacteria), urine cultures in 21 patients (12 with gram-negative bacteria), and tracheal aspirate/bronchoalveolar lavage in 39 patients (26 with gram-negative bacteria). Among the patients, 10 had a concurrent viral infection, six had candidiasis, and three had aspergillosis. Logistic regression identified an association between poor outcome and SAPS II at MICU admission (OR=1.07; 95%CI: 1.03-1.12), albumin (OR=0.89; 95%CI: 0.81-5.63), and vasopressor therapy (OR= 8.36; 95%CI: 1.51-46.33) at CRRT initiation. Conclusion Patients with S-AKI requiring CRRT represent a particularly vulnerable subgroup with a high risk of poor outcomes, especially when presenting with septic shock. In this single-center, low-resource MICU study, independent predictors of mortality were a high SAPS II score at MICU admission, as well as vasopressor requirement and hypoalbuminemia at CRRT initiation.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.